HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial.

AbstractOBJECTIVE:
ANTHEM-HF evaluated a novel autonomic regulation therapy (ART) via either left or right vagus nerve stimulation (VNS) in patients with heart failure (HF) and reduced ejection fraction (HFrEF).
METHODS AND RESULTS:
Sixty subjects (New York Heart Association [NYHA] functional class II-III, left ventricular ejection fraction (LVEF) ≤ 40%, left ventricular end-diastolic diameter ≥ 50 mm to < 80 mm) receiving optimal pharmacologic therapy were randomized at 10 sites. VNS systems were randomly implanted on the left (n = 31) or right (n = 29) side. All patients were successfully implanted and 59 were titrated over 10 weeks to a well tolerated stimulation intensity. One patient died 3 days after an embolic stroke that occurred during implantation. Common device-related adverse events after VNS titration were transient mild dysphonia, cough, and oropharyngeal pain, which were similar for left- and right-side VNS. After 6 months of ART, the adjusted left-right differences in LVEF, left ventricular end-systolic volume (LVESV), and left ventricular end-systolic diameter (LVESD) were 0.2% (95% CI -4.4 to 4.7), 3.7 mL (95% CI -7.0 to 14.4), and 1.3 mm (95% CI -0.9 to 3.6), respectively. In the combined population, absolute LVEF improved by 4.5% (95% CI 2.4-6.6), LVESV improved by -4.1 mL (95% CI -9.0 to 0.8), and LVESD improved by -1.7 mm (95% CI -2.8 to -0.7). Heart rate variability improved by 17 ms (95% CI 6.5-28) with minimal left-right difference. Six-minute walk distance improved an average of 56 m (95% CI 37-75); however, improvement was greater for right-side ART (77 m [95% CI 49-105]). NYHA functional class improved in 77% of patients (baseline to 6 months).
CONCLUSIONS:
Chronic open-loop ART via left- or right-side VNS is feasible and well tolerated in HFrEF patients. Safety and efficacy measures are encouraging and warrant further study.
AuthorsRajendra K Premchand, Kamal Sharma, Sanjay Mittal, Rufino Monteiro, Satyajit Dixit, Imad Libbus, Lorenzo A DiCarlo, Jeffrey L Ardell, Thomas S Rector, Badri Amurthur, Bruce H KenKnight, Inder S Anand
JournalJournal of cardiac failure (J Card Fail) Vol. 20 Issue 11 Pg. 808-16 (Nov 2014) ISSN: 1532-8414 [Electronic] United States
PMID25187002 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
CopyrightPublished by Elsevier Inc.
Topics
  • Aged
  • Autonomic Nervous System (physiopathology)
  • Feasibility Studies
  • Female
  • Follow-Up Studies
  • Heart Failure (physiopathology, therapy)
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Stroke Volume (physiology)
  • Time Factors
  • Treatment Outcome
  • Vagus Nerve Stimulation (methods)
  • Ventricular Function, Left (physiology)
  • Ventricular Remodeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: